Designed by the celebrated architect Erich Mendelsohn, the Weizmann House was more than a home for Dr. Chaim and Dr. Vera Weizmann — it was a statement of intent. Later becoming Israel's first presidential residence, it symbolized the central role of science and vision in the life of the nascent state.

Dr. Weizmann’s revolutionary fermentation methods earned him global recognition, but they were not just an academic achievement. The Weizmann scientists applied his techniques to create vital chemical compounds that supported the development of natural and agricultural products. This early work laid the foundation for applied research that directly served the needs of the emerging Jewish community in pre-state Israel (then under British rule), transforming scientific discovery into practical progress. This early work demonstrated a core principle that still drives us: fundamental research is the most powerful engine for real-world progress and prosperity.

On November 2, 1949, the Sieff Institute was officially renamed the Weizmann Institute of Science. At the ceremony, Dr. Weizmann declared, “We live in a pioneering land. We are pioneers settling desolate areas in agriculture and industry. Here, in Rehovot, we are involved in a pioneering act of a special kind: pioneering of science.” 
The date was chosen to coincide with both the anniversary of the Balfour Declaration and the month of Dr. Weizmann’s 75th birthday. The renaming marked the transition from a local research center into a national scientific institute, expanding our mission to push the boundaries of knowledge and cement our place on the world stage as a hub for transformative science. 

At the Weizmann Institute, Prof. Leo Sachs conducted pioneering studies that became the scientific bedrock for amniocentesis. This work, a major leap in prenatal diagnostics, reflected the Institute’s growing impact on global medical research.

One of the earliest computers in the world was built at the Weizmann Institute under the leadership of Chaim Leib Pekeris. The computer was named WEIZAC, which stands for Weizmann Automatic Computer. This monumental achievement didn’t just solve complex calculations; it ignited the nation's technology sector. That same year, the Institute also installed the country’s first ultracentrifuges and electron microscope, cementing the Weizmann Institute’s role as the home of cutting-edge tools for boundless exploration.

The Feinberg Graduate School opened in 1958, establishing the Weizmann Institute as a comprehensive academic institution. Its mission: to empower the most brilliant minds. Renamed the Weizmann School of Science in 2024, it has since trained over a quarter of Israel’s PhD students in science and mathematics, cultivating leaders who continue to push boundaries in research, industry, and public service.

Yeda, Israel’s first tech transfer company, was established to accelerate the journey from lab to life. Yeda’s mission was to identify brilliant discoveries by our scientists with the potential to become real-world solutions, protect them, and commercialize them. Yeda has since become a global model for bridging the gap between fundamental research and significant innovation.

Convinced that today's scientists must forge tomorrow's pioneers, Prof. Amos de Shalit launched a bold new commitment to education. The initiative unified disparate programs into a powerful force, creating dynamic curricula and empowering teachers to ignite curiosity in the next generation.

At the time, isolating specific biological materials like enzymes or antibodies was a slow, difficult process. Prof. Meir Wilchek changed this by developing affinity chromatography—a method that uses the natural "lock and key" recognition between molecules to separate them efficiently. This technique, along with his work on the avidin-biotin complex, gave scientists a standard tool used in laboratories worldwide today for everything from genetic research to drug development.

The Koffler Accelerator, part of the Canadian Centre for Nuclear Physics, became a landmark of the Weizmann Institute. Designed by architect Moshe Harel, the striking building features two futuristic concrete towers inspired by space-age design and science fiction. But it’s more than just a striking structure. This facility empowered generations of physicists to explore the deepest secrets of matter, embodying our commitment to building world-class infrastructure for fundamental science.

In a collaboration that would shape the future of the internet, Prof. Adi Shamir of the Weizmann Institute, together with Ron Rivest and Leonard Adleman, developed the RSA encryption protocol. As the first widely used public-key encryption system, it provided a secure mathematical foundation for internet communication that is still in use today. This work, recognized with the Turing Award, is a testament to the power of mathematical theory to solve immense practical challenges.

Profs. Moshe Oren and Varda Rotter of the Weizmann Institute made a discovery that would fundamentally change our understanding of cancer. They were among the first to uncover the function of p53, a key protein that helps prevent damaged cells from becoming cancerous. Their identification of the p53 gene revealed one of the body’s most critical defense mechanisms against tumors. This vital breakthrough opened up an entire field of cancer biology and continues to inform new therapeutic strategies today.

For 140 years, scientists—starting with Louis Pasteur—observed that certain crystals form mirror images of one another, but they couldn't explain the structural reason why. Profs. Meir Lahav and Leslie Leiserowitz finally solved this riddle. They proved that one can determine the spatial symmetry of a molecule, in particular the molecules of life, by understanding the morphology of the crystal in which the molecules are assembled and vice versa, resolving a long-standing question in stereochemistry.

Prof. Jacob Sagiv introduced the concept of self-assembled monolayers—a method for creating organized, single-molecule-thick layers on surfaces. This discovery effectively laid the groundwork for modern nanotechnology. His "bottom-up" approach effectively launched the field of modern nanotechnology and remains a core technique in materials science today.

The Weizmann Institute's iconic 'Solar Tower,' also known as The Canadian Solar Energy Centre, was built for solar energy research. The 52-meter tower used a field of computer-controlled mirrors (heliostats) to focus sunlight onto a central receiver for high-efficiency energy experiments. In 2014, the site was repurposed for cutting-edge research in personalized medicine, continuing its legacy of innovative science.

Prof. David Wallach isolated the receptors for Tumor Necrosis Factor (TNF or Cytokine), a protein that drives inflammation. By understanding how to block these receptors, his work paved the way for a new class of drugs, including Enbrel and Humira. These treatments now provide relief to millions of people suffering from chronic autoimmune conditions like rheumatoid arthritis and psoriasis.

The new Submicron Research Center, led by Prof. Moti Heiblum, provided a cutting-edge facility for exploring the fundamental laws of quantum physics. Its work ignited decades of transformative discoveries. This foundational research into the furthest reaches of matter ultimately earned Prof. Heiblum the prestigious Wolf Prize.

After more than three decades of relentless research, Copaxone®, the Weizmann-born treatment for multiple sclerosis, received FDA approval in 1997. The result of over 30 years of research at the Weizmann Institute, it became a major treatment for multiple sclerosis, improving the lives of millions worldwide. This moment marked a major triumph for the Institute and, more importantly, for the people whose lives were transformed by it.

With the founding of the Davidson Institute for Science Education, we created a powerful engine for spreading scientific curiosity across the nation. As our educational arm, the Davidson Institute makes the wonder of discovery accessible to everyone through nationwide programs, school partnerships, and hands-on learning, ensuring the legacy of exploration and critical thinking will thrive for generations to come.

Prof. Dan Yakir established the Yatir Research Station to explore the interplay between vegetation, the atmosphere, and the climate system, creating what is now a critical node in Biosphere-Atmosphere interaction research. The research station led prof. Yakir to win the Israel Prize in Earth Sciences in 2019. It continues to serve as an international beacon for scientists. Today, we are reaching further—extending 25 years of vital data with a new mobile station, now en route to Africa to expand our understanding of global environmental changes.

Prof. Ehud Shapiro and his team at the Weizmann Institute created the world’s first programmable biological computer. A remarkable machine made entirely from DNA and enzymes, it could perform logical operations with trillions of tiny computing units working in parallel. This breakthrough opened new frontiers in molecular computing, promising radical future applications in medicine.

Prof. Ada Yonath of the Weizmann Institute received the Nobel Prize in Chemistry, an honor celebrating her groundbreaking work uncovering the 3D structure of the ribosome using X-ray crystallography. Her pioneering work revealed how proteins are built in cells, advanced antibiotic research, and introduced cryo-crystallography as a key tool in structural biology. She was the first Israeli woman to win a Nobel Prize. Her journey exemplified the Weizmann spirit: a relentless pursuit of a bold idea, driven by passion and unbounded by convention.

Prof. Jacob Klein and his group at the Department of Molecular Chemistry and Materials Science discovered that angstrom-thin layers of water surrounding charges can act as powerful lubricants. This phenomenon, known as Hydration Lubrication, explains the low friction essential to healthy biological tissues. The discovery has led to a breakthrough treatment for osteoarthritis—a condition affecting 600 million people. This lipid-based technology, now being developed by the Israeli company Liposphere Ltd, was selected by IUPAC as one of the ‘Top Ten Emerging Technologies for 2024.

In a multidisciplinary collaboration, Prof. Ido Amit and Prof. Michal Schwartz deployed single-cell genomics to map the immune cells in the diseased brain. Their 2017 discovery of Disease-Associated Microglia (DAM) revealed these cells are "friends," not "foes," designed to protect the brain. This transformative insight shifted the paradigm for Alzheimer's research, opening bold new paths for therapies that empower the body’s own defenses.

A massive, systematic exploration by Prof. Rotem Sorek's group revealed 10 entirely new bacterial immune systems. This 2018 discovery transformed our understanding of the ancient war between bacteria and viruses. The breakthrough opened a new frontier, providing a treasure trove of potential biotech tools and proving that even in well-studied fields, boundless discoveries await.

Tookad®, the novel light-activated therapy for prostate cancer, receives approval. The treatment was born from the interdisciplinary research of Prof. Yoram Salomon and Prof. Avigdor Scherz from the Weizmann Institute, in collaboration with Steba Biotech. This breakthrough offers a targeted treatment for early-stage cancer, showcasing how our scientists transform fundamental discoveries into life-saving solutions.

With the inauguration of our first-ever medical school, the Weizmann Institute is poised to redefine medical training. The brand-new Miriam and Aaron Gutwirth Medical School opens this October 2025. The school’s integrated MD-PhD program is designed to cultivate a new generation of physician-scientists—leaders who are fluent in both clinical care and fundamental research.  By empowering them to bridge the gap between the lab and the clinic, we are investing in the innovators who will reshape healthcare and redefine what is medically possible.

The ULTRASAT telescope is set to revolutionize our understanding of the universe. This wide-field ultraviolet space telescope, led by researchers from the Weizmann Institute in collaboration with the Israel Space Agency, DESY, Israel Aerospace Industries, and Elbit Systems, marks a bold step into the unknown. Over the course of three years, it will capture brief, explosive cosmic events, unveiling the hidden dynamics of stellar explosions and black hole formations. We're not just imagining the universe’s secrets; we’re witnessing them, turning the impossible into groundbreaking discoveries.